Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia

Abstract Platelet transfusion is important in the prevention and treatment of bleeding in patients with acute myeloid leukemia (AML) after receiving intensive chemotherapy. However, platelet transfusion refractoriness (PTR) is an intractable clinical issue occurred in these patients. And its clinica...

Full description

Bibliographic Details
Main Authors: Xuelian Hu, Haodong Cai, Lu Zheng, Yi Luo, Jing Zhou, Yan Hui, Zhenyu Dai, Haolong Lin, Dengju Li, Yi Xiao, Liang Huang, Jianfeng Zhou
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Cancer Medicine
Subjects:
core binding factor acute myeloid leukemia
human leukocyte antigen
platelet transfusion refractoriness
risk factor
Online Access:https://doi.org/10.1002/cam4.3140

Internet

https://doi.org/10.1002/cam4.3140

Similar Items